Verge Genomics
Active, new domainAI-nativeWe use human data and AI to develop better drugs faster.
What it does
Verge uses artificial intelligence and human data to develop better drugs faster. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using it’s human-centric biology and chemistry platforms.
How it has moved
- new domain
The site moved to vergelabs.com, same company.
Next to it in Healthcare and bio · AI-powered drug discovery
- モジュラス株式会社Plug and Play
Modulus Discovery is a preclinical-stage technology-driven drug discovery firm.
- Synkrino BiotherapeuticsY Combinator S18
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…
- VemiCo LtdSOSV SOSV IndieBio RebelBio 08
From gut microbiota to therapeutics via AI and synthetic biology
- Numerion LabsY Combinator W15
Artificial intelligence for drug discovery.
- CardiaTec BiosciencesPlug and Play
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.
- OmniSciencePlug and Play
OmniScience is a leading AI organization advancing life science missions through unparalleled expertise in biology and data science.
- OwkinPlug and Play
Owkin combines life-science and machine learning expertise to make drug development and clinical trial design more targeted and more cost effective. Owkin's machine learning algorithms create models that predict disease evolution and treatment outcomes.
- RevorfPlug and Play
Revorf is a medical technology and drug discovery platform.